Earnings call Kuros Biosciences posted FY25 revenue of $146.1M (+72% YoY), adjusted EBITDA of $19.6M (13.4% margin), and first-ever net profit of $2.6M, exceeding guidance. Management guides for at ...

Abstract: This article presents novel approach to achieving record low voltage, large memory window (MW), high speed, and endurance for high-density 1T nonvolatile memory (NVM) with N-type and P-type ...

According to MarketsandMarkets, "Bromine Market by Derivative (Organobromine, Clear Brine Fluids, and Hydrogen Bromide), ...